Have your own idea? Try our Stock Screener
U.K. (FTSE) Biotech Industry Analysis
UpdatedJan 17, 2025
DataAggregated Company Financials
Companies22
- 7D7.6%
- 3M-9.1%
- 1Y-18.2%
- YTD3.7%
In the last week, the Biotech industry is up 7.6%, with Genus up 21%. In contrast, the industry has lost 18% in the last 12 months. Looking forward, earnings are forecast to grow by 38% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Jan 2025 | UK£2.7b | UK£842.6m | -UK£296,805,022.81 | 84.9x | -9.2x | 3.2x |
| Sun, 15 Dec 2024 | UK£2.6b | UK£841.7m | -UK£294,234,688.84 | 79.2x | -9x | 3.1x |
| Tue, 12 Nov 2024 | UK£2.8b | UK£840.5m | -UK£292,920,904.14 | 89.4x | -9.6x | 3.4x |
| Thu, 10 Oct 2024 | UK£3.0b | UK£840.2m | -UK£295,607,795.68 | 101.4x | -10.1x | 3.6x |
| Sat, 07 Sep 2024 | UK£2.7b | UK£830.5m | -UK£314,446,085.32 | 82.9x | -8.7x | 3.3x |
| Mon, 05 Aug 2024 | UK£2.6b | UK£838.1m | -UK£257,615,276.08 | 30.6x | -10.1x | 3.1x |
| Wed, 03 Jul 2024 | UK£2.5b | UK£835.8m | -UK£261,163,530.69 | 29.2x | -9.5x | 3x |
| Fri, 31 May 2024 | UK£3.0b | UK£836.3m | -UK£287,305,525.32 | 30.6x | -10.3x | 3.5x |
| Sun, 28 Apr 2024 | UK£3.1b | UK£895.9m | -UK£215,717,681.40 | 29.7x | -14.4x | 3.5x |
| Tue, 26 Mar 2024 | UK£3.1b | UK£900.9m | -UK£203,524,221.68 | 33.8x | -15.3x | 3.4x |
| Thu, 22 Feb 2024 | UK£3.2b | UK£913.3m | -UK£197,949,608.25 | 31.5x | -16.1x | 3.5x |
| Sat, 20 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,297,001.00 | 37.3x | -25.9x | 5x |
| Mon, 18 Dec 2023 | UK£6.1b | UK£1.3b | -UK£245,410,787.00 | 37x | -25x | 4.8x |
| Wed, 15 Nov 2023 | UK£6.4b | UK£1.3b | -UK£242,174,406.00 | 38.2x | -26.5x | 5x |
| Fri, 13 Oct 2023 | UK£6.7b | UK£1.3b | -UK£251,143,290.00 | 39.2x | -26.6x | 5.2x |
| Sun, 10 Sep 2023 | UK£6.5b | UK£1.3b | -UK£207,007,212.00 | 23.6x | -31.6x | 5.1x |
| Tue, 08 Aug 2023 | UK£6.8b | UK£1.3b | -UK£209,038,652.00 | 23.6x | -32.6x | 5.4x |
| Thu, 06 Jul 2023 | UK£6.7b | UK£1.3b | -UK£209,116,942.00 | 23.9x | -32.1x | 5.3x |
| Sat, 03 Jun 2023 | UK£7.0b | UK£1.3b | -UK£204,530,519.00 | 22.6x | -34.3x | 5.6x |
| Mon, 01 May 2023 | UK£7.1b | UK£1.3b | -UK£205,973,036.00 | 23.6x | -34.3x | 5.6x |
| Wed, 29 Mar 2023 | UK£7.1b | UK£1.2b | -UK£154,771,531.00 | 24.3x | -46x | 5.7x |
| Fri, 24 Feb 2023 | UK£7.5b | UK£1.2b | -UK£150,295,545.00 | 26.7x | -49.9x | 6.4x |
| Sun, 22 Jan 2023 | UK£7.7b | UK£1.2b | -UK£139,964,852.00 | 27.7x | -54.7x | 6.6x |
| Tue, 20 Dec 2022 | UK£7.4b | UK£1.2b | -UK£137,981,795.00 | 26.3x | -53.7x | 6.4x |
| Thu, 17 Nov 2022 | UK£7.7b | UK£1.2b | -UK£140,173,012.00 | 24.6x | -55x | 6.6x |
| Sat, 15 Oct 2022 | UK£52.6b | UK£1.2b | -UK£150,681,291.00 | 26.2x | -349.2x | 45.3x |
| Mon, 12 Sep 2022 | UK£7.5b | UK£1.1b | -UK£145,040,999.00 | 35.2x | -51.5x | 6.5x |
| Wed, 10 Aug 2022 | UK£7.3b | UK£1.1b | -UK£201,174,958.00 | 36.5x | -36.1x | 6.5x |
| Fri, 08 Jul 2022 | UK£7.1b | UK£1.1b | -UK£175,243,489.00 | 36.8x | -40.6x | 6.4x |
| Sun, 05 Jun 2022 | UK£7.1b | UK£1.1b | -UK£156,906,832.00 | 37.9x | -45.5x | 6.4x |
| Tue, 03 May 2022 | UK£7.4b | UK£1.1b | -UK£139,580,774.00 | 36.6x | -53.1x | 6.7x |
| Thu, 31 Mar 2022 | UK£7.5b | UK£1.1b | -UK£87,807,738.00 | 42.5x | -85.2x | 6.9x |
| Sat, 26 Feb 2022 | UK£7.6b | UK£1.1b | -UK£119,828,618.00 | 32.2x | -63.6x | 7x |
| Mon, 24 Jan 2022 | UK£9.2b | UK£1.1b | -UK£123,455,728.00 | 42.3x | -74.2x | 8.4x |
Price to Earnings Ratio
-74.2x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 8.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 0.96% | |
| Healthcare | -0.61% | |
| Biotech | 7.56% | |
| Biotech | 7.56% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GNS Genus | UK£18.02 | 21.9% +UK£212.8m | -19.1% | PE149.8x | |
| FARN Faron Pharmaceuticals Oy | UK£2.10 | 5.0% +UK£10.5m | -27.6% | PB188.6x | |
| AVCT Avacta Group | UK£0.53 | 3.9% +UK£7.3m | -49.0% | PS8.6x | |
| PRTC PureTech Health | UK£1.42 | 1.4% +UK£4.8m | -25.1% | PS886x | |
| SBTX SkinBioTherapeutics | UK£0.17 | 5.5% +UK£2.0m | 2.3% | PS31.9x |